BCMAxCD3 Bispecific Antibody Elranatamab Is Effective in Patient Myeloma Relapsed after BCMA CAR-T

被引：2
|
作者：
Keller, Alana L. [1 ]
Parzych, Sarah E. [1 ]
Reiman, Lauren T. [1 ]
Walker, Zachary J. [1 ]
Forsberg, Peter A. [2 ]
Sherbenou, Daniel W. [1 ]
机构：
[1] Univ Colorado, Div Hematol, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Div Hematol, Hlth Blood Disorders & Cell Therapies Ctr, Aurora, CO USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187385
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma
    Zhang, Hua
    Gao, Lei
    Liu, Li
    Wang, Jishi
    Wang, Sanbin
    Gao, Li
    Zhang, Cheng
    Liu, Yao
    Kong, Peiyan
    Liu, Jia
    He, Jiaping
    Han, Yu
    Shi, Hua
    He, Yan
    Ye, Xun
    Zhao, Yi
    Cao, Wei
    Shen, Lianjun
    Zhang, Xi
    BLOOD, 2019, 134
  • [2] A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells
    DiLillo, David J.
    Olson, Kara
    Mohrs, Katja
    Meagher, Thomas Craig
    Bray, Kevin
    Sineshchekova, Olga
    Startz, Thomas
    Kuhnert, Jessica
    Retter, Marc W.
    Godin, Stephen
    Sharma, Prachi
    Delfino, Frank
    Lin, John
    Smith, Eric
    Thurston, Gavin
    Kirshner, Jessica R.
    BLOOD ADVANCES, 2021, 5 (05) : 1291 - 1304
  • [3] Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Fandrei, David
    Seiffert, Sabine
    Rade, Michael
    Rieprecht, Susanne
    Gagelmann, Nico
    Born, Patrick
    Wiemers, Thomas
    Weidner, Heike
    Kreuz, Markus
    Schassberger, Tamara
    Kossmann, Jannik
    Mangold, Marlene
    Fuerst, Daniel
    Fischer, Luise
    Baber, Ronny
    Heyn, Simone
    Wang, Song Yau
    Bach, Enrica
    Hoffmann, Sandra
    Metzeler, Klaus H.
    Herling, Marco
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Koehl, Ulrike
    Friedrich, Maik
    Boldt, Andreas
    Reiche, Kristin
    Platzbecker, Uwe
    Vucinic, Vladan
    Merz, Maximilian
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 38 - 54
  • [4] REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells
    Dilillo, David J.
    Olson, Kara
    Mohrs, Katja
    Meagher, T. Craig
    Bray, Kevin
    Sineshchekova, Olga
    Startz, Thomas
    Retter, Marc
    Godin, Stephen
    Delfino, Frank
    Lin, John
    Smith, Eric
    Thurston, Olin Gavin
    Kirshner, Jessica R.
    BLOOD, 2018, 132
  • [5] Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma
    Chenggong Li
    Jia Xu
    Wenjing Luo
    Danying Liao
    Wei Xie
    Qiuzhe Wei
    Yinqiang Zhang
    Xindi Wang
    Zhuolin Wu
    Yun Kang
    Jin’e Zheng
    Wei Xiong
    Jun Deng
    Yu Hu
    Heng Mei
    Leukemia, 2024, 38 : 149 - 159
  • [6] Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma
    Li, Chenggong
    Xu, Jia
    Luo, Wenjing
    Liao, Danying
    Xie, Wei
    Wei, Qiuzhe
    Zhang, Yinqiang
    Wang, Xindi
    Wu, Zhuolin
    Kang, Yun
    Zheng, Jin'e
    Xiong, Wei
    Deng, Jun
    Hu, Yu
    Mei, Heng
    LEUKEMIA, 2024, 38 (01) : 149 - 159
  • [7] High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
    Yuanyan Tang
    Haisen Yin
    Xinying Zhao
    Dan Jin
    Yan Liang
    Tao Xiong
    Lu Li
    Wen Tang
    Jiangzhao Zhang
    Min Liu
    Zhuojun Yu
    Huimin Liu
    Sibin Zang
    Zhiping Huang
    Journal of Experimental & Clinical Cancer Research, 41
  • [8] High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
    Tang, Yuanyan
    Yin, Haisen
    Zhao, Xinying
    Jin, Dan
    Liang, Yan
    Xiong, Tao
    Li, Lu
    Tang, Wen
    Zhang, Jiangzhao
    Liu, Min
    Yu, Zhuojun
    Liu, Huimin
    Zang, Sibin
    Huang, Zhiping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [9] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng
    Li, Chenggong
    Jiang, Huiwen
    Zhao, Xinying
    Huang, Zhiping
    Jin, Dan
    Guo, Tao
    Kou, Haiming
    Liu, Lin
    Tang, Lu
    Yin, Ping
    Wang, Zhihui
    Ai, Lisha
    Ke, Sha
    Xia, Yimeng
    Deng, Jun
    Chen, Lei
    Cai, Li
    Sun, Chunyan
    Xia, Linghui
    Hua, Gaoquan
    Hu, Yu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [10] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Heng Mei
    Chenggong Li
    Huiwen Jiang
    Xinying Zhao
    Zhiping Huang
    Dan Jin
    Tao Guo
    Haiming Kou
    Lin Liu
    Lu Tang
    Ping Yin
    Zhihui Wang
    Lisha Ai
    Sha Ke
    Yimeng Xia
    Jun Deng
    Lei Chen
    Li Cai
    Chunyan Sun
    Linghui Xia
    Gaoquan Hua
    Yu Hu
    Journal of Hematology & Oncology, 14
12345